Blog
Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On
Julie Rubinstein, the President and COO of Adaptive Biotechnologies Corporation (NASDAQ:ADPT), reported the sale of 38,120 shares of Common Stock for approximately $554,000 in a set of transactions
2 Stocks With Monster Potential to Hold Through the Next Decade of Chaos
The next decade will see seismic shifts across many major industries. In particular, both the energy and transportation sectors will be reimagined thanks to rapid advancements in artificial
Should You Add a Defense ETF to Your Portfolio in April?
The current war in Iran has disrupted the global geopolitical landscape and the outlook for U.S. stocks. It has also sent defense stocks soaring.
Over the past year, these three of the biggest
An Opening of the Strait of Hormuz Affects More Than Oil
The Strait of Hormuz blockade has caused investors, consumers, and businesses to focus on surging oil prices. Oil affects the cost of every product, since land vehicles, ships, and aircraft need it
CoreWeave and Nebius Have Outperformed Every "Magnificent Seven" Artificial Intelligence (AI) Stock This Year. Can It Last?
The "Magnificent Seven" cohort of stocks hasn't had the greatest run in 2026. These are the year-to-date stock performances for each company:
Not a single one of those stocks is in the black for the
Here's Why Illinois Tool Works Stock Lost Ground in March
Illinois Tool Works (NYSE: ITW) investors must be feeling frustrated by events in 2026. The U.S. manufacturing sector has been in a slowdown over the last couple of years, and as soon as it starts
Don't Miss the April 15 IRA Deadline. It Could Cost You Thousands
IRAs aren't as widely used as 401(k)s, but they're effective retirement accounts that can play a valuable role in people's retirement finances. They're flexible like standard brokerage accounts, but
This Stock Is the Best Way to Buy Into SpaceX Before Its IPO, but Could You Be Better Off Waiting?
SpaceX has confidentially filed to go public, seeking to raise up to $75 billion at what has now grown to an estimated $2 trillion-plus valuation. The company, which includes its flagship rocket
Bitcoin Is Down 45% From Its All-Time High -- Here's What History Says Happens Next
The first thing that you need to know about Bitcoin (CRYPTO: BTC) is that it's highly cyclical. The world's top cryptocurrency typically follows a four-year cycle of boom-or-bust, with three very
S&P 500 Sell-Off: 1 Vanguard ETF I'm Loading Up On Right Now
The stock market has taken a beating this year, with the S&P 500 (SNPINDEX: ^GSPC) down by around 5% from its peak, as of this writing. While it can be tempting to stop investing amid all the chaos
Stock-Split Euphoria Is Back, With 5 Vanguard ETFs -- Totaling $724 Billion in Combined Assets -- Taking the Plunge
Although artificial intelligence (AI) has been dominating the headlines on Wall Street for years, it's not the only trend that's powered the Dow Jones Industrial Average, S&P 500, and Nasdaq
Will Palantir Reach $230 Per Share? This Wall Street Analyst Thinks So.
Palantir Technologies (NASDAQ: PLTR) is among the most popular investments in artificial intelligence (AI) that anyone can make, thanks to its dominant platform and emerging agentic AI service. It's
Inter Parfums CEO Sells $1.8 Million in Stock With Shares Down 10% Year Over Year
Jean Madar, the CEO of Inter Parfums (NASDAQ:IPAR), reported the indirect sale of 20,000 shares of common stock on April 2, 2026 for a transaction value of about $1.82 million, according to a SEC
The Case for Ethereum as the Most Useful Cryptocurrency in Existence
In many ways, referring to Ethereum (CRYPTO: ETH) as only a "cryptocurrency" does it a major disservice. Ethereum is much more than that -- it is also a blockchain ecosystem and a global
3 Industrial Dividend Stocks for Reliable Income in 2026
Investors seek dividend stocks as a haven during economic uncertainty, and one sector investors can turn to is industrials.
Broadly, the sector is filled with mature companies that offer stability
C3.ai Shares Down 55% in a Year as CEO Sells $429K in Stock After $133 Million Quarterly Loss
Stephen Bradley Ehikian, the chief executive officer of C3.ai (NYSE:AI), reported the disposition of 52,194 shares of Common Stock via open-market sale and 47,316 shares via direct gifting
Arcutis Stock Up 65% as Director Sells 10,000 Shares Under 10b5-1 Plan. Here's What Investors Should Know
Director Howard G. Welgus reported the sale of 10,000 shares of Arcutis Biotherapeutics (NASDAQ:ARQT) on April 1, 2026, according to a SEC Form 4 filing.
Transaction value based on SEC Form 4
Geopolitical Risk Is Back. Here's How Smart Investors Are Repositioning Their Portfolios in April.
When the U.S. and Israel attacked Iran on Feb. 28, roughly 20% of the world's oil supply was put at risk of being heavily delayed or cut off entirely. Now, with oil shipments delayed and a global
Why I'm Buying Growth Stocks While Everyone Else Is Panic-Selling Tech
The war with Iran brought about a major shift in the stock market.
While energy stocks have (not surprisingly) gotten a boost, there has been a general rotation out of technology and large-cap
2 Defense Stocks Worth Buying as Global Tensions Continue
No matter if the war in Iran ends tomorrow, the world of warfare has fundamentally changed. Like with airborne drones in the Ukraine and Russian conflict, the United States and its allies are
Can Netflix Stock Double in 5 Years? Yes -- But Only If These 3 Things Happen
Netflix (NASDAQ: NFLX) doesn't look like a typical double candidate anymore. It's already huge, it leads global streaming, and growth isn't as fast as it used to be. On the surface, that usually
Spyre CEO Sells $740K in Stock After 300% Surge as Key Q3 Data Nears
Cameron Turtle, the chief executive officer of Spyre Therapeutics (NASDAQ:SYRE), reported the direct sale of 15,000 shares of common stock for approximately $740K on April 1, 2026, according to a
These Dividend Stocks Are Smart Buys for $130, No Matter What the Market Does
Equity markets have experienced some turmoil in recent weeks. Amid worsening geopolitical tensions, trade wars, and other challenges, some investors feel they have no choice but to withdraw their
This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area
CRISPR Therapeutics (NASDAQ: CRSP) has significantly lagged broader equities over the past five years. There are several reasons for that. Challenging economic conditions have led investors to
Is the AI Gold Rush Over? Costco and Walmart Just Delivered a Sobering $163 Billion Warning to Shareholders of Nvidia, Palantir, and Other Red-Hot AI Stocks.
Over the past three years, artificial intelligence (AI) stocks have driven overall market gains -- investors, from the smallest retail investor to billionaire hedge fund managers, have piled into


